For More Information
Call (888) 220-0905
Drug Alerts
Related News
Since the FDA announced in June of 2011 that the diabetes drug Actos may be linked to bladder cancer, thousands of patients affected by the disease have come forward to pursue legal action against Takeda Pharmaceuticals over the defective drug.
Read More
The U.S. Food and Drug Administration warned last year that those who take the medication Actos for their type 2 diabetes may have an increased chance of developing bladder cancer. The advisory came as a shock to hundreds of thousands who believed the drug to be a safer alternative to Avandia.
Read More
Helpful Links
Actos is a drug prescribed to millions of people around the world to treat type II diabetes. However, the FDA, EMA, and Health Canada have recently warned that long term use of the drug may increase the risk of bladder cancer.
The warnings come after research in Europe and Canada showed a heightened risk of bladder cancer associated with the use of Actos for more than a year. The drug has been recalled in Germany and France, but is still widely used in the United States. Due to the failure of the manufacturer, Takeda Pharmaceuticals, to properly warn of the risks, thousands may have been affected.
Many have questioned whether the victims can join in an Actos Class Action Lawsuit for their damages. However, these lawsuits are actually being filed individually through a special federal court, which has advantages and may result in greater compensation for those affected.
A qualified attorney can discuss your case today to let you know what help is available.
If you have taken Actos and been diagnosed with bladder cancer, contact us to learn how a mass tort MDL case can provide substantial financial compensation for you and your family over an Actos Class Action Lawsuit. Attorneys are available to speak today.
 |
Actos |  |
Side Effects |  |
Warnings |
 |
Bladder Cancer |  |
Local Help |  |
Legal Options |
June 8, 2012 – For over a year, researchers have cautioned of study results showing that long-term use of the diabetes drug Actos is associated with an increased risk of bladder cancer.
In June of 2011, the FDA first told patients of the dangers after a study by the French Medicines Agency found as much as a 40% increased risk of bladder cancer with Actos use. The findings also prompted Germany and France to ban the drug.
Health Canada also recently issued a warning after their independent study found troubling relations between Actos and bladder cancer. The British Medical Journal published a study on May 31, 2012 by researchers at McGill University in Montreal showing the increased bladder cancer risks from long-term Actos use may actually be as high as 83%.
Read More
Following warnings last year by the United States and several countries in Europe, the top drug safety agency in Canada announced this month that they were also warning patients about the safety of the diabetes drug Actos.
On April 19, 2012, Health Canada issued a warning that Actos may cause an increased risk of bladder cancer. They also announced that they will require additional warnings to the packaging of the drug to alert patients of the risk.
Health Canada is much like the Food and Drug Administration in the U.S. or the European Medicines Agency in Europe. Both agencies warned of the safety of the drug last summer.
Read More
There has been a health advisory issued by the Food and Drug administration to patients taking the diabetes drug Actos. It warns that use of the drug for longer than a year may lead to Actos health risks.
The advisory came on June 15, 2011, after a study was published by the French Medicines Agency of more than 155,000 people which showed that patients taking the drug Actos may face a nearly 40% higher risk of developing bladder cancer.
France and Germany have already banned the drug, while in the United States it remains on the market pending further research into the health risks.
Nearly 70,000 people in the United States suffer from bladder cancer each year. Bladder cancer can often times be treatable due to the fact that the symptoms allow for early detection, however, if not treated this serious disease can prove to be fatal.
Takeda Pharmaceuticals, the manufacturer of the drug, has denied that there are health risks and refuses to recall the drug.
However, thousands of people have sought legal help after being diagnosed with bladder cancer following Actos use. Instead of one large Actos class action lawsuit, the thousands of individual cases are being consolidated into a federal multidistrict litigation court.
There is still legal help available for those just discovering their condition.
If you were diagnosed with bladder cancer after taking Actos, contact us today to learn about your legal options. We are available 24 hours a day to answer your questions and provide you with help.
